CD70 CAR-T cells

BIOLOGICAL6 trials

Sponsors

Chongqing Precision Biotech Co., Ltd, Weijia Fang, MD

Conditions

Advanced CancerAdvanced Solid TumorCervix CancerGynecologic CancerMetastatic CancerMetastatic TumorOvarian CancerRenal Cell Carcinoma

Phase 1

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Chongqing Precision Biotech Co., LtdAdvanced Solid Tumor, Cervix Cancer, Metastatic Tumor +2

Start: 2021-12-31End: 2024-12-31Target: 36Updated: 2023-08-18

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

Chongqing Precision Biotech Co., LtdAdvanced Cancer, Metastatic Tumor, Renal Cell Carcinoma

Start: 2021-12-31End: 2024-12-31Target: 24Updated: 2023-08-18

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

Chongqing Precision Biotech Co., LtdAdvanced Solid Tumor, Cervix Cancer, Metastatic Tumor +2

Start: 2022-07-17End: 2025-07-17Target: 48Updated: 2023-08-18

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

RecruitingNCT05518253

Weijia Fang, MDAdvanced Solid Tumor, Cervix Cancer, Metastatic Tumor +2

Start: 2022-05-30End: 2027-05-30Target: 30Updated: 2025-05-31

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

RecruitingNCT06010875

Chongqing Precision Biotech Co., LtdAdvanced Cancer, Cervix Cancer, Metastatic Cancer +2

Start: 2023-11-30End: 2026-09-30Target: 48Updated: 2023-11-08

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer

RecruitingNCT06215950

Chongqing Precision Biotech Co., LtdAdvanced Cancer, Cervix Cancer, Gynecologic Cancer +2

Start: 2024-01-10End: 2027-12-31Target: 36Updated: 2024-01-22